Almac invests in biocatalysis lauding cost and environmental benefits

from Outsourcing-Pharma Podcast · host William Reed Ltd

Almac invests $4m in biocatalysis R&D, describing such technologies as the way forward for the cost efficient production of highly chiral APIs and intermediates.

Episode metadata supplied by the publisher feed · Published Oct 12, 2010

Embed this episode

Attribution link and audio player

NOW PLAYING

Almac invests in biocatalysis lauding cost and environmental benefits

0:00 2:29

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Outsourcing-Pharma Podcast?

This episode is 2 minutes long.

When was this Outsourcing-Pharma Podcast episode published?

This episode was published on October 12, 2010.

Can I download this Outsourcing-Pharma Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!